The Development of Vaccines against SARS-CoV-2 Virus. An Overview
Keywords:
SARS-CoV-2; COVID-19; vaccine; viral vector; coronaviru s ; live attenuated virus; protein sub-unit; virus-like particles (VLP)
Abstract
The COVID-19 is a zoonotic disease and is caused by the SARS-CoV-2 virus It is the type of coronavirus The structural proteins of the virus include the spike S protein membrane M protein envelop protein E and nucleocapsid N protein The replication of the virus utilizes all structural proteins The infection of the host occurs due to the binding of the spike protein to the angiotensin-converting enzyme II ACE II It is a positive-sense single-stranded RNA virus belong to the family Coronavridae The recent outbreak of this disease has caused a lethal pandemic The previous knowledge of SARS-CoV has helped to develop a vaccine against SARS-CoV-2 also The humoral and cell-mediated immune response is protective against this infection The antibody response generated against the S protein which is the most exposed protein of SARS-CoV has been shown to protect from infection in mouse models Multiple studies have shown that the antibodies generated against the N protein of SARS-CoV are highly immunogenic and abundantly expressed protein during infections
Downloads
- Article PDF
- TEI XML Kaleidoscope (download in zip)* (Beta by AI)
- Lens* NISO JATS XML (Beta by AI)
- HTML Kaleidoscope* (Beta by AI)
- DBK XML Kaleidoscope (download in zip)* (Beta by AI)
- LaTeX pdf Kaleidoscope* (Beta by AI)
- EPUB Kaleidoscope* (Beta by AI)
- MD Kaleidoscope* (Beta by AI)
- FO Kaleidoscope* (Beta by AI)
- BIB Kaleidoscope* (Beta by AI)
- LaTeX Kaleidoscope* (Beta by AI)
How to Cite
Published
2021-05-15
Issue
Section
License
Copyright (c) 2021 Authors and Global Journals Private Limited
This work is licensed under a Creative Commons Attribution 4.0 International License.